Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: a retrospective chart review

BACKGROUND: Molecular testing has been used for cytologically indeterminate thyroid nodules (Bethesda III and IV), where the risk of malignancy is 10–40%. However, to date, the role of molecular testing in cytologically suspicious or positive for malignancy (Bethesda V and VI) thyroid nodules has be...

Descripción completa

Detalles Bibliográficos
Autores principales: Hier, Jessica, Avior, Galit, Pusztaszeri, Marc, Krasner, Joshua R., Alyouha, Noura, Forest, Veronique-Isabelle, Hier, Michael P., Mlynarek, Alex, Richardson, Keith, Sadeghi, Nader, Tamilia, Michael, Payne, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082804/
https://www.ncbi.nlm.nih.gov/pubmed/33910629
http://dx.doi.org/10.1186/s40463-021-00500-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082804/
https://www.ncbi.nlm.nih.gov/pubmed/33910629
http://dx.doi.org/10.1186/s40463-021-00500-6

Ejemplares similares